During the past decade, KLIMED Marek Klimkiewicz conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KLIMED Marek Klimkiewicz" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Corbus Pharmaceuticals Inc." with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KLIMED Marek Klimkiewicz" #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "KLIMED Marek Klimkiewicz" are "Dermatitis, Atopic" (2 trials), "Ulcerative Colitis" (2 trials), "Alzheimer Disease" (1 trials), "Atopic Dermatitis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "KLIMED Marek Klimkiewicz" in a lesser frequency.

Most popular intervention types in "KLIMED Marek Klimkiewicz" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "UTTR1147A" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "KLIMED Marek Klimkiewicz" are 11 trials for "All" genders.

Currently, there are NaN active trials in "KLIMED Marek Klimkiewicz". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in KLIMED Marek Klimkiewicz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in KLIMED Marek Klimkiewicz, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".